Tonix Pharmaceuticals Holding Corp. (TNXP)
17.14
+1.24
(+7.80%)
USD |
NASDAQ |
Jan 16, 16:00
16.80
-0.34
(-1.98%)
After-Hours: 20:00
Tonix Pharmaceuticals Shareholders Equity (Quarterly): 231.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Amicus Therapeutics, Inc. | 230.42M |
| Soligenix, Inc. | 7.598M |
| Citius Oncology, Inc. | 44.87M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.44M |
| Total Liabilities (Quarterly) | 21.30M |
| Debt to Equity Ratio | 0.0018 |
| Current Ratio | 9.894 |
| Net Debt Paydown Yield | 0.99% |